Financial Info

Financial Highlights  |  Ratios

Valuation P/E 20.36x   P/S 1.17x   P/B 2.48x   EPS 1915.94	Financial Strength Quick Ratio (MRQ) 0.62x   Current Ratio (MRQ) 1.14x   Total Debt/Equity (MRQ) 1.67x   Total Debt/Assets (MRQ) 0.62x	Operating Ratios Assets Turnover (TTM) 0.82x   Inventory Turnover (TTM) 1.89x   Receivables Turnover (TTM) 2.77x
Profitability Gross Margin (TTM) 28.96%   Operating Margin (TTM) 7.03%   EBIT Margin (TTM) 7.03%   Profit Margin (TTM) 5.66%	Management Effectiveness ROA (TTM) 4.61%   ROE (TTM) 12.49%   ROIC (TTM) 18.08%	Growth Rate Diluted EPS Growth (TTM) -22.38%   Sales Growth (TTM) 3.65%   Profit Growth (TTM) -9.12%   Asset Growth (TTM) 13.87%

MRQ: Most Recent Quarter    TTM: Trailing 12 Mon.    LFY: Last Fiscal Year

Compared to other companies in the same field, Agimexpharm Pharmaceutical Joint Stock Company is a small-scaled company in terms of assets, annual revenue, and owner equity. In terms of ROE, it ranks at number 4 out of 10 companies. The company has its own competitive edge in the market thanks...